Your Search Returned 9 tagged news reports
Contact Information Available for logged-in reporters only Description Researchers at Moffitt Cancer Center have completed a phase II clinical trial to determine the safety and efficacy of dasatinib for patients with higher-risk myelodysplastic
Tags:
The trial found that the treatment was safe, causing no significant side effects. Bone marrow transplants are given to boost the patient's damaged immune system, but the transplant is sometime rejected by the body, resulting in serious side effects,
Tags:
The answer appears to lie in the discovery of previously undetected genetic differences in the DNA of patients and unrelated marrow donors. Citations Science Translational Medicine ©2012 Newswise, Inc 215 5th St.
Tags:
Hockey player Mandi Schwartz is scheduled to undergo a potentially life-saving cancer treatment set next week in a Seattle hospital. Schwartz, a native of Wilcox, Sask., who plays hockey at Yale University, will undergo a transplant using stem cells
Tags:
Researchers have linked a genetic pattern to the likelihood that patients with a severe form of childhood leukemia will relapse. The finding could lead doctors to screen for the pattern and treat those who have it more aggressively from the time of
Tags:
The Arizona Republic Five-year-old Cecilia Nham has been in the hospital for the better part of the past two months. In early March, she started vomiting and having bone pain and diarrhea, accompanied by fevers. Her father, Hoang, said her stomach
Tags:
Adding a complete blood count test may help predict leukemia treatment outcomes, U.S. researchers say. Researchers at Houston's Children's Cancer Hospital at the University of Texas M.D. Anderson Cancer Center say combining the results of two
Tags:
Notable differences in survival in patients with acute leukemia' (illustration) Photo: Sebastian Scheiner Patients who have blood stem cell transplants survive just as long on average as those who undergo more invasive procedure of having a bone
Tags:
the probabilities were 62.3 percent for bone marrow and 47.1 percent for blood stem cell transplants. "Different patient groups might still benefit from transplantation with bone marrow," the researchers concluded. Add a Comment More from
Tags: